Back to Newsroom

Eutilex Names Agustin de la Calle Chief Business Officer

SEOUL, South Korea, Nov. 7, 2016 /PRNewswire/ — Eutilex Co. Ltd. today announced that it has appointed Agustin de la Calle, Ph.D., as chief business officer. In this capacity, Dr. de la Calle will focus on the establishment of licensing, co-development, joint research and investment opportunities involving Eutilex’s preclinical and clinical-stage pipeline of immuno-oncology candidates. He will report to Byoung S. Kwon, Ph.D., the company’s founder and CEO.

Click here to read the full release